Sign in

CIK 0001393434

  • Large accelerated filer

OCULAR THERAPEUTIX, INC

Sign in to watch
Ticker
OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-357-4000
Business address
14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
Former names
I-THERAPEUTIX INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$799,174
in 9 filings, $788K under 10b5-1 plans

Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-31 Notman Donald Chief Operating Officer Sale −1,099 $10.24 $11K 366,529
2026-02-12 Notman Donald Chief Operating Officer Sale −11,446 $9.04 $103K 366,356
2026-02-04 Notman Donald Chief Operating Officer Sale −6,035 $8.54 $52K 377,802
2026-02-02 Notman Donald Chief Operating Officer Sale −5,455 $9.14 $50K 383,837
2026-01-02 Notman Donald See Remarks Grant or award +79,112 389,292
2026-01-02 Notman Donald See Remarks Grant or award · Stock Option (Right to Buy) +240,932 240,932
2025-09-02 Notman Donald See Remarks Sale −1,066 $12.43 $13K 308,807
2025-02-11 Notman Donald See Remarks Grant or award +115,000 308,444
2025-02-11 Notman Donald See Remarks Grant or award · Stock Option (Right to Buy) +344,115 344,115
2025-02-04 Notman Donald See Remarks Sale −11,119 $7.81 $87K 193,444
2025-01-31 Notman Donald See Remarks Sale −6,301 $7.84 $49K 204,563
2024-08-29 Notman Donald See Remarks Grant or award +11,034 208,988
2024-08-29 Notman Donald See Remarks Grant or award · Stock Option (Right to Buy) +33,602 33,602
2024-02-05 Notman Donald Chief Financial Officer Sale +6,212 $4.86 $30K 195,356
2024-02-03 Notman Donald Chief Financial Officer Grant or award +61,636 201,568
2024-02-03 Notman Donald Chief Financial Officer Grant or award · Stock Option (Right to Buy) +185,000 185,000
2024-01-31 Notman Donald Chief Financial Officer Sale −6,433 $4.95 $32K 139,932
2023-02-06 Notman Donald Chief Financial Officer Sale −6,476 $4.24 $27K 139,387
2023-01-30 Notman Donald Chief Financial Officer Grant or award +55,556 145,863
2023-01-30 Notman Donald Chief Financial Officer Grant or award · Stock Option (Right to Buy) +166,667 166,667

Page 1 of 2 · 25 trades